Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence.

Nadai Y, Held K, Joseph S, Ahmed MIM, Hoffmann VS, Peterhoff D, Missanga M, Bauer A, Joachim A, Reimer U, Zerweck J, McCormack S, Cope AV, Tatoud R, Shattock RJ, Robb ML, Sandstroem EG, Hoelscher M, Maboko L, Bakari M, Kroidl A, Wagner R, Weber J, Pollakis G, Geldmacher C.

Front Immunol. 2019 Apr 24;10:717. doi: 10.3389/fimmu.2019.00717. eCollection 2019.

2.

Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre.

Gould VMW, Francis JN, Anderson KJ, Georges B, Cope AV, Tregoning JS.

Front Microbiol. 2017 May 17;8:900. doi: 10.3389/fmicb.2017.00900. eCollection 2017.

3.

A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.

Joseph S, Quinn K, Greenwood A, Cope AV, McKay PF, Hayes PJ, Kopycinski JT, Gilmour J, Miller AN, Geldmacher C, Nadai Y, Ahmed MI, Montefiori DC, Dally L, Bouliotis G, Lewis DJ, Tatoud R, Wagner R, Esteban M, Shattock RJ, McCormack S, Weber J.

Front Immunol. 2017 Feb 22;8:149. doi: 10.3389/fimmu.2017.00149. eCollection 2017.

4.

Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.

Cosgrove CA, Lacey CJ, Cope AV, Bartolf A, Morris G, Yan C, Baden S, Cole T, Carter D, Brodnicki E, Shen X, Joseph S, DeRosa SC, Peng L, Yu X, Ferrari G, Seaman M, Montefiori DC, Frahm N, Tomaras GD, Stöhr W, McCormack S, Shattock RJ.

PLoS One. 2016 May 9;11(5):e0152038. doi: 10.1371/journal.pone.0152038. eCollection 2016.

5.

Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.

McKay PF, Cope AV, Mann JF, Joseph S, Esteban M, Tatoud R, Carter D, Reed SG, Weber J, Shattock RJ.

PLoS One. 2014 Jan 23;9(1):e84707. doi: 10.1371/journal.pone.0084707. eCollection 2014.

6.

Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.

Regoes RR, Bowen EF, Cope AV, Gor D, Hassan-Walker AF, Prentice HG, Johnson MA, Sweny P, Burroughs AK, Griffiths PD, Bonhoeffer S, Emery VC.

Proc Biol Sci. 2006 Aug 7;273(1596):1961-7.

7.

Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation.

Griffiths PD, Cope AV, Hassan-Walker AF, Emery VC.

Transpl Infect Dis. 1999 Sep;1(3):179-86. Review.

PMID:
11428988
8.

Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation.

Emery VC, Cope AV, Sabin CA, Burroughs AK, Rolles K, Lazzarotto T, Landini MP, Brojanac S, Wise J, Maine GT.

J Infect Dis. 2000 Dec;182(6):1610-5. Epub 2000 Oct 26.

PMID:
11069231
9.

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.

Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD.

Lancet. 2000 Jun 10;355(9220):2032-6.

PMID:
10885354
10.

Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus.

Griffiths PD, Ait-Khaled M, Bearcroft CP, Clark DA, Quaglia A, Davies SE, Burroughs AK, Rolles K, Kidd IM, Knight SN, Noibi SM, Cope AV, Phillips AN, Emery VC.

J Med Virol. 1999 Dec;59(4):496-501.

PMID:
10534732
11.

The dynamics of human cytomegalovirus replication in vivo.

Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD.

J Exp Med. 1999 Jul 19;190(2):177-82.

12.

Transcription of the human cytomegalovirus natural killer decoy gene, UL18, in vitro and in vivo.

Hassan-Walker AF, Cope AV, Griffiths PD, Emery VC.

J Gen Virol. 1998 Sep;79 ( Pt 9):2113-6.

PMID:
9747719
14.

Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation.

Cope AV, Sweny P, Sabin C, Rees L, Griffiths PD, Emery VC.

J Med Virol. 1997 Jun;52(2):200-5.

PMID:
9179769

Supplemental Content

Support Center